menu
    • menu

    Company profile for Iridex Corporation

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Established in 1989, IRIDEX Corporation stands as a global pioneer in the development, manufacturing, and promotion of cutting-edge and adaptable laser-based medical systems, delivery devices, and consumable instrumentation within the field of ophthalmology. Our unwavering commitment to customer success is reflected in comprehensive technical, clinical, and service support programs. Striving for excellence, IRIDEX upholds a st...
    Established in 1989, IRIDEX Corporation stands as a global pioneer in the development, manufacturing, and promotion of cutting-edge and adaptable laser-based medical systems, delivery devices, and consumable instrumentation within the field of ophthalmology. Our unwavering commitment to customer success is reflected in comprehensive technical, clinical, and service support programs. Striving for excellence, IRIDEX upholds a standard of superior technology to achieve exceptional outcomes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Iridex CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Mountain View, CA 94043
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.iridex.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/iridex/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/iridex

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Iridex Partners With Eyeprogpo To Enhance Retina Laser Tech
    Iridex Partners With Eyeprogpo To Enhance Retina Laser Tech

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3269622/0/en/Iridex-Announces-New-Partnership-with-EyeProGPO-to-Expand-Member-Access-to-Retina-Laser-Technology.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Iridex Reports Fourth Quarter & Full Year 2025 Financial Results
    Iridex Reports Fourth Quarter & Full Year 2025 Financial Results

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263410/0/en/Iridex-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Iridex To Release 2025 Financial Results On March 26, 2026
    Iridex To Release 2025 Financial Results On March 26, 2026

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255088/0/en/Iridex-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-March-26-2026.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Iridex Announces Plans To Relocate Headquarters
    Iridex Announces Plans To Relocate Headquarters

    02 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/02/3230108/0/en/Iridex-Announces-Plans-to-Relocate-Headquarters.html

    GLOBENEWSWIRE
    02 Feb 2026
    Share Share
    Iridex Reveals 2025 Q4 & Full-Year Operational, Financial Results
    Iridex Reveals 2025 Q4 & Full-Year Operational, Financial Results

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216723/0/en/Iridex-Announces-Preliminary-Operational-and-Financial-Results-for-Fourth-Quarter-and-Full-Year-2025.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    New Independent Study on MicroPulse Transscleral Laser Treatment
    New Independent Study on MicroPulse Transscleral Laser Treatment

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203755/0/en/Iridex-Announces-the-Publication-of-an-Independent-Study-Demonstrating-Safe-and-Effective-Retreatment-with-Transscleral-Laser-Treatment-Using-MicroPulse-Technology-in-Glaucoma-Mana.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search